Distribution of salicylic acid in human stratum corneum following topical application in vivo: A comparison of six different formulations

International Journal of Pharmaceutics

Volumn 188, Issue 2, 1999, Pages 145-153

  Tsai, Jui Chen ^a   Chuang, Shan An ^a   Hsu, May Ying ^a   Sheu, Hamm Ming ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Formulation; In vivo; Salicylic acid; Stratum corneum; Tape stripping

Indexed keywords

ACETYLSALICYLIC ACID; LACTIC ACID PLUS SALICYLIC ACID;

ADULT; ARTICLE; COLLOID; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG UPTAKE; FEMALE; HUMAN; NORMAL HUMAN; OINTMENT; PRIORITY JOURNAL; STRATUM CORNEUM; TOPICAL DRUG ADMINISTRATION;

ADHESIVES; ADMINISTRATION, CUTANEOUS; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMIS; FEMALE; HUMANS; KERATOLYTIC AGENTS; PHARMACEUTIC AIDS; SALICYLIC ACID;

EID: 0032828440     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00217-3     Document Type: Article

References (14)

1. Salicylic Acid. 1996;2613-2615 The American Society of Health-System Pharmacists, Bethesda, MD.
2. Baden H.P., Alper J.C. A keratolytic gel containing salicylic acid in propylene glycol. J. Invest. Dermatol. 61:1973;330-333.
3. Chren M.M., Bickers D.R. Surface-acting drugs. Goodman Gilman A., Goodman L.S., Rall T.W., Murad F. The Pharmacological Basis of Therapeutics. 8th ed. 1990;1587 Macmillan, New York.
4. Christensen M.S., Nacht S., Kantor S.L., Gans E.H. A method for measuring desquamation and its use for assessing the effects of some common exfoliants. J. Invest. Dermatol. 71:1978;289-294.
5. Davies M., Marks R. Studies on the effect of salicylic acid on normal skin. Br. J. Dermatol. 95:1976;187-192.
6. Lodén M., Boström P., Kneczke M. Distribution and keratolytic effect of salicylic acid and urea in human skin. Skin Pharmacol. 8:1995;173-178.
7. Murakami T., Yoshioka M., Okamoto I., Yumoto R., Higashi Y., Okahara K., Yata N. Effect of ointment bases on topical and transdermal delivery of salicylic acid in rats: evaluation by skin microdialysis. J. Pharm. Pharmacol. 50:1998;55-61.
8. Nook T.H. In vivo measurement of the keratolytic effect of salicylic acid in three ointment formulations. Br. J. Dermatol. 117:1987;243-245.
9. Pershing L.K., Silver B.S., Krueger G.G., Shah V.P., Skelly J.P. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching assay. Pharm. Res. 9:1992;45-51.
10. Pershing L.K., Lambert L., Wright E.D., Shah V.P., Williams R.L. Topical 0.05% betamethasone dipropionate: pharmacokinetic and pharmacodynamic dose-response studies in humans. Arch. Dermatol. 130:1994;740-747.
11. Pershing L.K., Corlett J., Jorgensen C. In vivo pharmacokinetics and pharmacodynamics of topical ketoconazole and miconazole in human stratum corneum. Antimicrob. Agents Chemother. 38:1994;90-95.
12. Rawlings A., Harding C., Watkinson A., Banks J., Ackerman C., Sabin R. The effect of glycerol and humidity on desmosone degradation in stratum corneum. Arch. Dermatol. Res. 287:1995;457-464.
13. Roberts D.L., Marshall R., Marks R. Detection of the action of salicylic acid on the normal stratum corneum. Br. J. Dermatol. 103:1980;191-196.
14. Tong A.K.F., Vickers C.F.H. Topical noncorticosteroid therapy. Fitzpatrick T.B., Eisen A.Z., Wolff K., Freedberg I.M., Austen K.F. 4th ed. Dermatology in General Medicine. 2:1993;2855 McGraw-Hill, New York.